JP Morgan raised its rating on Intuitive Surgical ISRG from Neutral to Overweight and increased its price target from $610 to $625.
JP Morgan noted, "While there are clearly some headwinds to the Intuitive Surgical (ISRG) story, notably the recent dVP decline and industry-wide European challenges, we find the risk/reward increasingly compelling, in light of the meaningful opportunities emerging in partial nephrectomy, cholecystectomy, colorectal surgery and other areas (thoracic, etc.) – which, collectively, should more than offset the dVP softness and drive upside to Street estimates for the next several years."
Intuitive Surgical closed at $494.58 on Friday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in